MEDIROM Healthcare Technologies Inc.
MRM · NASDAQ
12/31/2024 | 6/30/2024 | 12/31/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Revenue | $4,823,853 | $3,475,281 | $3,585,153 | $3,242,790 |
| % Growth | 38.8% | -3.1% | 10.6% | – |
| Cost of Goods Sold | $3,154,132 | $2,898,717 | $2,695,244 | $2,563,831 |
| Gross Profit | $1,669,721 | $576,564 | $889,909 | $678,959 |
| % Margin | 34.6% | 16.6% | 24.8% | 20.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $436,458 | $0 | $809,192 | $0 |
| SG&A Expenses | $1,028,277 | $1,213,238 | $971,225 | $989,222 |
| Sales & Mktg Exp. | $77,681 | $0 | $162,033 | $0 |
| Other Operating Expenses | $22,872 | $0 | $0 | $0 |
| Operating Expenses | $1,051,149 | $1,213,238 | $971,225 | $1,013,434 |
| Operating Income | $618,572 | -$636,674 | -$81,316 | -$310,263 |
| % Margin | 12.8% | -18.3% | -2.3% | -9.6% |
| Other Income/Exp. Net | $13,911 | $51,904 | $453,269 | -$41,068 |
| Pre-Tax Income | $632,483 | -$584,770 | $371,953 | -$351,331 |
| Tax Expense | -$94,083 | $3,605 | -$98,162 | $3,735 |
| Net Income | $730,944 | -$582,181 | $470,470 | -$355,066 |
| % Margin | 15.2% | -16.8% | 13.1% | -10.9% |
| EPS | 68.9 | -118.56 | 86.32 | -72.72 |
| % Growth | 158.1% | -237.3% | 218.7% | – |
| EPS Diluted | 118.73 | -118.56 | 86.32 | -72.72 |
| Weighted Avg Shares Out | 5,107 | 4,910 | 5,451 | 4,883 |
| Weighted Avg Shares Out Dil | 5,852 | 4,910 | 5,451 | 4,883 |
| Supplemental Information | – | – | – | – |
| Interest Income | $8 | $0 | -$15,745 | $16,856 |
| Interest Expense | $0 | $20,627 | $0 | $0 |
| Depreciation & Amortization | $93,936 | $196,102 | $151,746 | $100,849 |
| EBITDA | $828,068 | -$440,572 | $70,430 | -$209,414 |
| % Margin | 17.2% | -12.7% | 2% | -6.5% |